These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. An evaluation of the safety and immunogenicity of a five-component acellular pertussis, diphtheria, and tetanus toxoid vaccine (DTaP) when combined with a Haemophilus influenzae type b-tetanus toxoid conjugate vaccine (PRP-T) in Taiwanese infants. Lee CY, Thipphawong J, Huang LM, Lee PI, Chiu HH, Lin W, Debois H, Harrison D, Xie F, Barreto L. Pediatrics; 1999 Jan; 103(1):25-30. PubMed ID: 9917435 [Abstract] [Full Text] [Related]
9. Impact of Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine on responses to concurrently administered diphtheria-tetanus-pertussis vaccine. Clemens JD, Ferreccio C, Levine MM, Horwitz I, Rao MR, Edwards KM, Fritzell B. JAMA; 1992 Feb 05; 267(5):673-8. PubMed ID: 1731134 [Abstract] [Full Text] [Related]
15. Economisation of vaccination against Haemophilus influenzae type b: a randomised trial of immunogenicity of fractional-dose and two-dose regimens. Lagos R, Valenzuela MT, Levine OS, Losonsky GA, Erazo A, Wasserman SS, Levine MM. Lancet; 1998 May 16; 351(9114):1472-6. PubMed ID: 9605803 [Abstract] [Full Text] [Related]
17. Large scale, postlicensure, selective vaccination of Chilean infants with PRP-T conjugate vaccine: practicality and effectiveness in preventing invasive Haemophilus influenzae type b infections. Lagos R, Horwitz I, Toro J, San Martin O, Abrego P, Bustamante C, Wasserman SS, Levine OS, Levine MM. Pediatr Infect Dis J; 1996 Mar 16; 15(3):216-22. PubMed ID: 8852909 [Abstract] [Full Text] [Related]